NAGIOS: RODERIC FUNCIONANDO

Alternative to oral dicoumarin anticoagulants:Considerations in dental care

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Alternative to oral dicoumarin anticoagulants:Considerations in dental care

Mostra el registre parcial de l'element

dc.contributor.author Mingarro de León, Ana es
dc.contributor.author Chaveli López, Begonya es
dc.date.accessioned 2014-05-22T09:42:27Z
dc.date.available 2014-05-22T09:42:27Z
dc.date.issued 2013 es
dc.identifier.citation Mingarro de León, Ana ; Chaveli López, Begonya. Alternative to oral dicoumarin anticoagulants:Considerations in dental care. En: Journal of Clinical and Experimental Dentistry, 2013, Vol. 5, No. 5: 273-278 es
dc.identifier.uri http://hdl.handle.net/10550/35350
dc.description.abstract Introduction: For over 50 years, vitamin K antagonists such as warfarin (Aldocumar®) and acenocoumarol (Sintrom ®) have been the gold standard for reducing the risk of cerebrovascular events. In the last 5 years alternative anticoagulants have been evaluated that act directly upon a concrete target within the coagulation cascade, thereby affording a more predictable anticoagulant effect. The present study offers an update on the new oral anticoagulants and reviews the implications referred to the dental care of patients administered these substances. Material and methods: An exhaustive PubMed-Medline and Cochrane Library search was made of the main alternatives to conventional oral anticoagulation, covering those studies published in English and Spanish over the last 10 years. Specialized textbooks and pharmaceutical catalogs were also consulted. A total of 184 articles were identified, of which 76 met the inclusion criteria. Results: The new oral anticoagulants dabigatran, rivaroxaban and apixaban are safe and effective, and offer a series of advantages, including rapid action, no need for constant monitoring, few drug and food interactions, and a broad therapeutic margin. These drugs are expensive, however, and some lack a specific antidote, while others must be administered twice a day. Regarding the dental treatment of patients receiving these drugs, suspension or modification of the background medication is not required when performing invasive dental procedures, except where indicated by the prescribing physician. Conclusions: The new oral anticoagulants do not pose significantly greater risks than conventional oral anticoagulants when providing invasive dental treatment, and their suspension is not strictly required in such situations. en_US
dc.subject Odontología es
dc.subject Ciencias de la salud es
dc.title Alternative to oral dicoumarin anticoagulants:Considerations in dental care es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.type.hasVersion VoR es_ES

Visualització       (610.5Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques